Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 3/20 | 0.44 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | FAAH | O00519 | 7/20 | 0.39 |
| ▸ | CES1 | P23141 | 5/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23501398 | 0.86 | FAAH (0.52) | CES2FAAHCES1MEN1CYP1A2 | |
| SCHEMBL8637200 | 0.83 | GGPS1 (0.47) | GGPS1CES2MEN1KMT2AHSD17B10 | |
| SCHEMBL27347514 | 0.81 | GGPS1 (0.43) | GGPS1CES2MEN1KMT2AHSD17B10 | |
| SCHEMBL11310630 | 0.81 | FFAR1 (0.31) | — | |
| SCHEMBL6048466 | 0.78 | CES1 (0.39) | GGPS1CES2CES1FDPS | |
| SCHEMBL19133167 | 0.77 | CES2 (0.45) | GGPS1CES2FAAHCES1MEN1 | |
| SCHEMBL8895992 | 0.77 | CES2 (0.45) | GGPS1CES2FAAHCES1MEN1 | |
| SCHEMBL13267820 | 0.77 | CES2 (0.45) | GGPS1CES2FAAHCES1MEN1 | |
| SCHEMBL14338625 | 0.75 | ALDH1A1 (0.38) | — | |
| SCHEMBL25058848 | 0.75 | CES2 (0.44) | GGPS1CES2FAAHCES1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9585362-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2017-03-07 | — | — | US | disclosed |
| US-20160286753-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2016-10-06 | — | — | US | disclosed |
| US-9447364-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2016-09-20 | — | — | US | disclosed |
| US-20150247109-A1 | FRAGRANCE COMPOUNDS | Givaudan, S.A. (CH) | 2015-09-03 | — | — | US | disclosed |
| US-9057041-B2 | Fragrance compounds | Givaudan, S.A. (CH) | 2015-06-16 | — | — | US | disclosed |
| US-20140031270-A1 | Fragrance Compounds | GIVAUDAN S.A. (CH) | 2014-01-30 | — | — | US | disclosed |
| US-8575386-B2 | Fragrance compounds | GIVAUDAN S.A. (CH) | 2013-11-05 | — | — | US | disclosed |
| US-20090202464-A1 | Fragrance Compounds | GIVAUDAN S.A. (CH) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090202464-A1 | Fragrance Compounds | OR10J3, OR51E2, TAS2R5 | GGPS1 4655/4885CES2 1364/4885FAAH 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.